維維股份(600300.SH)延期回覆上海證券交易所問詢函
格隆匯3月19日丨維維股份(600300.SH)公佈,2020年3月16日,公司收到上海證券交易所上市公司監管一部下發的《關於對維維食品飲料股份有限公司購買關聯方房產相關事項的問詢函》。
公司收到《問詢函》後高度重視,積極組織相關人員就《問詢函》涉及的事項進行逐項核實,積極推進回覆工作。鑑於《問詢函》部分回覆內容尚需進一步補充和完善。為確保回覆內容真實、準確、完整,經向上海證券交易所申請,公司將延期回覆《問詢函》,預計於2020年3月24日前完成對《問詢函》的回覆工作並及時履行相關信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.